GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,854,000 | +31.2% | 91,715 | +1.7% | 0.00% | 0.0% |
Q4 2018 | $3,701,000 | -48.2% | 90,152 | -52.0% | 0.00% | +50.0% |
Q3 2018 | $7,140,000 | +54.2% | 187,904 | +83.4% | 0.00% | -33.3% |
Q2 2018 | $4,630,000 | +3.2% | 102,429 | +10.3% | 0.00% | 0.0% |
Q1 2018 | $4,485,000 | +26.5% | 92,862 | +3.1% | 0.00% | +50.0% |
Q4 2017 | $3,546,000 | -9.4% | 90,111 | -28.5% | 0.00% | -33.3% |
Q3 2017 | $3,915,000 | -43.9% | 126,073 | -50.6% | 0.00% | -40.0% |
Q2 2017 | $6,975,000 | +44.9% | 255,045 | +95.3% | 0.01% | +66.7% |
Q1 2017 | $4,813,000 | +258.4% | 130,606 | +40.5% | 0.00% | +200.0% |
Q4 2016 | $1,343,000 | -7.0% | 92,934 | +48.3% | 0.00% | 0.0% |
Q3 2016 | $1,444,000 | +94.3% | 62,651 | +40.0% | 0.00% | 0.0% |
Q2 2016 | $743,000 | +112.9% | 44,761 | +103.3% | 0.00% | – |
Q1 2016 | $349,000 | -65.6% | 22,013 | -29.9% | 0.00% | -100.0% |
Q4 2015 | $1,016,000 | +16.9% | 31,415 | +52.5% | 0.00% | 0.0% |
Q3 2015 | $869,000 | – | 20,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |